Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Application of Machine-Learning Algorithms for Multiclass Classification of Microcytic Anemia Revealed That a Minimum Required Number of Hematological Parameters Is Enough to Achieve High Diagnostic Accuracy.

International journal of laboratory hematology·2025
Same author

Aggressive T-Cell Large Granular Lymphocyte Leukemia With the Unusual Double-Negative CD4-/CD8-/TCRαβ+ Phenotype; Report of Two Cases and Review of the Literature.

International journal of laboratory hematology·2025
Same author

Red Cell Distribution Width (RDW), Platelets and Platelet Index MPV/PLT Ratio as Specific Time Point Predictive Variables of Survival Outcomes in COVID-19 Hospitalized Patients.

Journal of clinical medicine·2025
Same author

Candidemia in an Orthopedic Patient Detected Coincidentally by Peripheral Blood Smear.

Diagnostics (Basel, Switzerland)·2024
Same author

FLAER Revealed Normally Expected Non-PNH FLAER-Dim Immature Myeloid Cells (CD117+/CD34-) In Bone Marrow Aspirates and Could Be Utilized as a Marker of Hierarchical Hematopoiesis.

International journal of laboratory hematology·2024
Same author

A case report of a Chediak-Higashi syndrome diagnosed by peripheral blood smear.

International journal of laboratory hematology·2024

Related Experiment Video

Updated: Dec 21, 2025

Culture of myeloid dendritic cells from bone marrow precursors
06:39

Culture of myeloid dendritic cells from bone marrow precursors

Published on: July 25, 2008

23.0K

Dendritic Cell Leukemia: a Review.

Nikolaos J Tsagarakis1, Georgios Paterakis2

  • 1Department of Immunology, "G. Gennimatas" General Hospital, Mesogion Avenue 154, 11527, Athens, Greece. nikolaostsagarakis@gmail.com.

Current Oncology Reports
|May 17, 2020
PubMed
Summary
This summary is machine-generated.

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare, aggressive cancer. Early diagnosis and aggressive treatment, including chemotherapy and stem cell transplant, offer the best outcomes.

Keywords:
BPDCN diagnosisBPDCN reviewBlastic plasmacytoid dendritic cell neoplasmDendritic cell leukemiaImmunophenotypeTherapy

More Related Videos

Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes
11:48

Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes

Published on: May 31, 2018

11.9K
Generation of Human Monocyte-derived Dendritic Cells from Whole Blood
07:35

Generation of Human Monocyte-derived Dendritic Cells from Whole Blood

Published on: December 24, 2016

21.0K

Related Experiment Videos

Last Updated: Dec 21, 2025

Culture of myeloid dendritic cells from bone marrow precursors
06:39

Culture of myeloid dendritic cells from bone marrow precursors

Published on: July 25, 2008

23.0K
Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes
11:48

Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes

Published on: May 31, 2018

11.9K
Generation of Human Monocyte-derived Dendritic Cells from Whole Blood
07:35

Generation of Human Monocyte-derived Dendritic Cells from Whole Blood

Published on: December 24, 2016

21.0K

Area of Science:

  • Hematology
  • Oncology
  • Immunology

Background:

  • Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematologic malignancy.
  • Its diverse clinical presentations and challenging diagnosis require updated understanding.

Purpose of the Study:

  • To review the clinical, diagnostic, and therapeutic features of BPDCN.
  • To highlight recent findings and future directions in BPDCN management.

Main Methods:

  • Review of case reports and series.
  • Analysis of clinical, molecular, and immunophenotypic data.
  • Synthesis of current therapeutic approaches and outcomes.

Main Results:

  • BPDCN exhibits diverse clinical presentations, including leukemic and atypical forms.
  • Diagnostic markers like CD4, TCL1, CD123, CD56, and CD303 are indicative but diagnosis can be challenging.
  • Adults benefit from chemotherapy (ALL-type) and hematopoietic stem cell transplantation (HSCT); children may respond to chemotherapy alone.

Conclusions:

  • BPDCN is an aggressive malignancy requiring prompt, intensive therapy.
  • Standardized treatment guidelines are needed, but novel agents offer encouraging prospects.
  • Further research into CD123-directed therapies is warranted.